MedDataX Logo

Shift Characteristics Affect Handover Duration and Rates.

NCT ID: NCT02359071

Last Updated: 2015-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

267 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-09-30

Study Completion Date

2013-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim of our study was to analyze the independent factors affecting handover duration in Emergency Department. The secondary aim was to identify the factors affecting Emergency Department handover rates.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary aim in this study was to analyze the independent factors affecting handover duration in Emergency Department. Our secondary aim was to identify the factors affecting the Emergency Department handover rates. To better analyze independent variables, we dichotomized the data. First, we dichotomized handover duration into two groups according to the median handoff time of 20 minutes. Second, we divided handover rates into two groups using the median rate of handovers per shift, which was 3.87%.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Handover Duration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Handovers with lower durations

equal or lower than 20 minutes

handover duration, handover rate

Intervention Type OTHER

To better analyze independent variables, we dichotomized the data. First, we dichotomized handover duration into two groups according to the median handoff time of 20 minutes. Second, we divided handover rates into two groups using the median rate of handovers per shift, which was 3.87%.

handovers with higher durations

Higher than 20 minutes

handover duration, handover rate

Intervention Type OTHER

To better analyze independent variables, we dichotomized the data. First, we dichotomized handover duration into two groups according to the median handoff time of 20 minutes. Second, we divided handover rates into two groups using the median rate of handovers per shift, which was 3.87%.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

handover duration, handover rate

To better analyze independent variables, we dichotomized the data. First, we dichotomized handover duration into two groups according to the median handoff time of 20 minutes. Second, we divided handover rates into two groups using the median rate of handovers per shift, which was 3.87%.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

The day and night shift handover , which are the interactive, verbal, bedside, and face-to-face interactions between the outgoing and incoming medical staff, were included.

Exclusion Criteria

Handover locations other than bedside (n=3), handover methods except verbal communication (by paper (n=2)), and the use of information technology (n=1) were excluded to standardize the procedure.
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ankara Training and Research Hospital

OTHER

Sponsor Role collaborator

Duzce university-DUZCE

UNKNOWN

Sponsor Role collaborator

Recep Tayyip Erdoğan University-RIZE

UNKNOWN

Sponsor Role collaborator

Mustafa Kemal University

OTHER

Sponsor Role collaborator

DerinceTraining and Research Hospital- KOCAELI

UNKNOWN

Sponsor Role collaborator

GATA Haydarpaşa Training Hospital, Istanbul

OTHER

Sponsor Role collaborator

Ataturk University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Atıf

Atıf BAYRAMIGLU

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ali Karakus, Assoc. prof

Role: PRINCIPAL_INVESTIGATOR

Mustafa Kemal University

Ayhan Sarıtas, Assoc. prof

Role: PRINCIPAL_INVESTIGATOR

Duzce University

Gulhan Kurtoglu, specialist

Role: PRINCIPAL_INVESTIGATOR

Ankara Training and Research Hospital

Ozlem Bilir, Assist. Prof

Role: PRINCIPAL_INVESTIGATOR

Recep Tayyip Erdogan University

Ayhan Akoz, Assoc. prof.

Role: PRINCIPAL_INVESTIGATOR

Ataturk University

Murat Eroglu, Assoc. prof

Role: PRINCIPAL_INVESTIGATOR

GATA Haydarpasa Military Hospital

Onur Karakayali, specialist

Role: PRINCIPAL_INVESTIGATOR

DerinceTraining and Research Hospital

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Atıf-001

Identifier Type: -

Identifier Source: org_study_id